Movano, based in Pleasanton, California and led by founder and CEO Michael Leabman, develops a painless, smart, and simple wearable non-invasive continuous glucose monitor. The company was founded in 2018 and since then has raised nearly $30M to advance its technology. Movano’s core product is a wearable CGM that uses non-invasive sensing to enable individuals and their healthcare partners to measure and manage health conditions. The recent financing will be used to expand both internal and external testing efforts. Movano also intends to accelerate miniaturization of its technology into a single chip that can fit inside a wearable. Financially, the company closed a $12.5M bridge round as part of its ongoing fundraising.

Total raised

$13M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2020